title: Early lymphocyte recovery predicts superior outcomes after unmanipulated haploidentical blood and marrow transplant for acute myeloid leukemia.
abstract: We investigated whether early lymphocyte recovery, after unmanipulated haploidentical blood and marrow transplant (HBMT), affected clinical outcomes in 134 patients with acute myeloid leukemia (AML). Lymphocyte recovery was based on the absolute lymphocyte count on day 30 (ALC-30). Patients with high ALC-30 (≥294 cells/μL) had higher overall survival (OS) (77.6% vs 59.7%, P=.020) and higher leukemia-free survival (LFS) (74.6% vs 53.7%, P=.016) than those with low ALC-30 values. Multivariate analysis demonstrated that a high ALC-30 was associated with improved overall survival (HR: 0.443, 95% CI: 0.233-0.841; P=.013) and LFS (HR: 0.499, 95% CI: 0.275-0.906; P=.022). Our results suggest that the ALC-30 can predict a superior outcome after unmanipulated HBMT.
authors.affiliation: Beijing Key Laboratory of HSCT, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China.
authors.forename: Qiang
authors.initials: Q
authors.lastname: Fu
authors.affiliation: Beijing Key Laboratory of HSCT, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China.
authors.forename: Lan-Ping
authors.initials: LP
authors.lastname: Xu
authors.affiliation: Beijing Key Laboratory of HSCT, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China.
authors.forename: Xiao-Hui
authors.initials: XH
authors.lastname: Zhang
authors.affiliation: Beijing Key Laboratory of HSCT, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China.
authors.forename: Yu
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Beijing Key Laboratory of HSCT, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China.
authors.forename: Ying-Jun
authors.initials: YJ
authors.lastname: Chang
authors.affiliation: Beijing Key Laboratory of HSCT, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China.|Peking-Tsinghua Center for Life Sciences, Beijing, China.
authors.forename: Xiao-Jun
authors.initials: XJ
authors.lastname: Huang
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000379:methods*; D002648:Child; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000601:surgery*; D018655:Lymphocyte Count; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D019172:Transplantation Conditioning / Q000379:methods*; D016896:Treatment Outcome; D055815:Young Adult
keywords: absolute lymphocyte count; acute myeloid leukemia; immune recovery; lymphocyte recovery; transplant outcomes; unmanipulated haploidentical blood and marrow transplant